Detalhe da pesquisa
1.
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
N Engl J Med;
387(13): 1185-1195, 2022 09 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36027559
2.
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists.
Diabetologia;
67(2): 246-262, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38127122
3.
Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure.
Circulation;
148(13): 1011-1022, 2023 09 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37621153
4.
Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial.
Circulation;
147(3): 201-211, 2023 01 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36335479
5.
Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis.
Circulation;
147(22): 1640-1653, 2023 05 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37051919
6.
Performance of Different Risk Scores for the Detection of Atrial Fibrillation Among Patients With Cryptogenic Stroke.
Stroke;
55(2): 454-462, 2024 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38174570
7.
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial.
Lancet;
402(10408): 1147-1157, 2023 09 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37634520
8.
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
N Engl J Med;
385(24): 2252-2263, 2021 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34449181
9.
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
N Engl J Med;
385(16): 1451-1461, 2021 10 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34449189
10.
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
N Engl J Med;
384(2): 105-116, 2021 01 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33185990
11.
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure.
Am Heart J;
267: 52-61, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37972677
12.
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial.
Am Heart J;
2024 May 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38740532
13.
Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial.
J Card Fail;
30(4): 525-537, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37820896
14.
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis.
Diabetes Obes Metab;
2024 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38558314
15.
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
Diabetes Obes Metab;
26(1): 191-200, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37814928
16.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Ann Intern Med;
176(12): 1606-1616, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38048573
17.
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
Eur Heart J;
44(5): 396-407, 2023 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36478225
18.
Pre-treatment bicarbonate levels and decongestion by acetazolamide: the ADVOR trial.
Eur Heart J;
44(22): 1995-2005, 2023 Jun 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37138385
19.
Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial.
Eur Heart J;
44(37): 3672-3682, 2023 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37623428
20.
Albuminuria as a marker of systemic congestion in patients with heart failure.
Eur Heart J;
44(5): 368-380, 2023 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36148485